<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05120336</url>
  </required_header>
  <id_info>
    <org_study_id>NBK_TUE004</org_study_id>
    <nct_id>NCT05120336</nct_id>
  </id_info>
  <brief_title>tVNS Effects on Motivation in Depression</brief_title>
  <official_title>The Effects of Transcutaneous Vagus Nerve Stimulation on Motivation in Major Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universit채t T체bingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Attaining goals or rewards commonly entails response costs. In light of cost and benefits,&#xD;
      how do participants decide what effort should be put in to give it a shot? Figuratively, you&#xD;
      may &quot;go with your gut&quot;, but the literal contribution of the gut-brain axis in allocating&#xD;
      effort is poorly understood to date. Here, the investigators propose to investigate&#xD;
      non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy&#xD;
      metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and&#xD;
      behavioral effects of the stimulation remain largely elusive, the investigators will use&#xD;
      computational modeling of instrumental behavior and determine the primary metabolic effects&#xD;
      of the stimulation. The investigators hypothesize that tVNS will lead to activation of&#xD;
      afferent targets in the brain. In turn, the elicited brain activation is expected to mediate&#xD;
      the cognitive effects of the stimulation. This may affect both sides of the utility equation&#xD;
      because anti-depressive effects may correspond to boosting the benefit of effort whereas&#xD;
      anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the&#xD;
      cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more&#xD;
      widespread use as a treatment in mental disorders that are characterized by metabolic&#xD;
      alterations such as depression.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 11, 2019</start_date>
  <completion_date type="Actual">January 29, 2021</completion_date>
  <primary_completion_date type="Actual">January 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Food reward ratings</measure>
    <time_frame>during stimulation (compared to sham)</time_frame>
    <description>Operationalized via visual analogue scale ratings of liking [-100 - 100] and wanting [0-100] in a food cue reactivity task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Motivation to work for rewards: frequency of button presses to gain food an monetary rewards</measure>
    <time_frame>during stimulation (compared to sham)</time_frame>
    <description>Operationalized via the relative frequency of button presses on an Xbox controller in an effort allocation task during either the first seconds of each trial (invigoration) or each complete trial (maintenance)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reward learning: correct choices</measure>
    <time_frame>during stimulation (compared to sham)</time_frame>
    <description>Operationalized via number of correct value-based choices in a valenced go/no-go learning task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive and negative mood</measure>
    <time_frame>Pre and post stimulation (compared to sham)</time_frame>
    <description>Operationalized via visual analogue ratings (0-100) of positive and negative affect schedule mood items</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Non-depressed control participants: sham first, active taVNS second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with major depressive disorders: sham first, active taVNS second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with major depressive disorders: active taVNS first, sham second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-depressed control participants: active taVNS first, sham second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous vagus nerve stimulation</intervention_name>
    <description>Non-invasive brain stimulation technique that is used to stimulate vagal afferent projections to the nucleus of the solitary tract. Invasive VNS has been approved for the treatment of treatment-resistant depression.</description>
    <arm_group_label>Non-depressed control participants: active taVNS first, sham second</arm_group_label>
    <arm_group_label>Non-depressed control participants: sham first, active taVNS second</arm_group_label>
    <arm_group_label>Patients with major depressive disorders: active taVNS first, sham second</arm_group_label>
    <arm_group_label>Patients with major depressive disorders: sham first, active taVNS second</arm_group_label>
    <other_name>transcutaneous auricular vagus nerve stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  30 kg/m^2 &gt; BMI &gt; 18.5 kg/m^2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        lifetime&#xD;
&#xD;
          -  brain injury&#xD;
&#xD;
          -  coronary heart disease and occurred apoplexy&#xD;
&#xD;
          -  schizophrenia&#xD;
&#xD;
          -  bipolar disorder&#xD;
&#xD;
          -  implants (e.g., cochlea implant)&#xD;
&#xD;
          -  asthma&#xD;
&#xD;
             12 month&#xD;
&#xD;
          -  severe substance use disorders (DSM-V), except tobacco&#xD;
&#xD;
          -  obessive compulsive disorder&#xD;
&#xD;
          -  somatic symptom disorder&#xD;
&#xD;
          -  eating disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Psychiatry &amp; Psychotherapy, University of T체bingen</name>
      <address>
        <city>T체bingen</city>
        <state>BW</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vagus nerve stimulation</keyword>
  <keyword>food reward</keyword>
  <keyword>anhedonia</keyword>
  <keyword>vigor</keyword>
  <keyword>reward learning</keyword>
  <keyword>mood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

